Works matching IS 03407004 AND DT 2025 AND VI 74 AND IP 6

Results: 21

GD2-CAR NK-92 cell activity against neuroblastoma cells is insusceptible to TIGIT knockout.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04010-6

By:

Jünemann, Wiebke;
Bley, Isabelle;
Rekowski, Laura;
Klokow, Marianne;
Herppich, Susanne;
Müller, Ingo;
Cornils, Kerstin

Publication type:

Article

In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04023-1

By:

Xu, Yan;
Mcmillan, Alexandra;
Gupta, Nikesh;
Lemke-Miltner, Caitlin D.;
Rataan, Aseel O.;
Areecheewakul, Sudartip;
Bhat, Divya S.;
Lanzel, Emily A.;
Geary, Sean M.;
Simons, Andrean L.;
Weiner, George J.;
Salem, Aliasger K.

Publication type:

Article

Transcriptomic and proteomic characterization of cell and protein biomarkers of checkpoint inhibitor-induced liver injury.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04033-z

By:

Ji, Changhua;
Kumpf, Steven;
Qian, Jessie;
Federspiel, Joel D.;
Sheehan, Mark;
Capunitan, Darien;
Atallah, Edmond;
Astbury, Stuart;
Arat, Seda;
Oziolor, Elias;
Ocana, Mireia Fernandez;
Ramaiah, Shashi K.;
Grove, Jane;
Aithal, Guruprasad P.;
Lanz, Thomas A.

Publication type:

Article

Targeting interleukin-2-inducible T cell kinase ameliorates immune-mediated aplastic anemia.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04040-0

By:

Li, Weiwang;
Lian, Yu;
Zhang, Lele;
Li, Ruonan;
Liang, Qian;
Mao, Jin;
Qiu, Chen;
Li, Haoyuan;
Huang, Ke;
Li, Qiaoli;
Shen, Yucan;
Yang, Fei;
Tian, Linzhu;
Xiao, Tingfang;
Gu, Shilong;
Pan, Hong;
Gao, Zhen;
Zhao, Jingyu;
Fang, Liwei;
Ge, Meili

Publication type:

Article

Correction: Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer.

Published in:

2025

By:

Tak, Eunyoung;
An, Hye-In;
Lee, Amy Sinyoung;
Han, Kyuyoung;
Choi, Jiwan;
Kim, Hyung-don;
Hong, Yong Sang;
Kim, Sun Young;
Choi, Eun Kyung;
Kim, Jeong Eun;
Kim, Tae Won

Publication type:

Correction Notice

Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world study.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04038-8

By:

Wang, Yilin;
Pan, Shida;
Tian, Jiahe;
Wang, Jianing;
Yu, Yingying;
Wang, Siyu;
Li, Fengyi;
Yang, Luo;
Liu, Xiaomeng;
Shen, Yingjuan;
Qiu, Qin;
Luan, Junqing;
Jia, Mengdie;
Xiong, Chuyue;
Duan, Xuanxuan;
Wang, Fu-Sheng;
Meng, Fanping

Publication type:

Article

Dynamics of tertiary lymphoid structures and immune cross talk in early versus advanced colorectal cancer: potential implications for immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04027-x

By:

Chen, Zixu;
Hu, Bang;
Cai, Keyu;
Gao, Han;
Xian, Zhenyu;
Zhang, Shuang;
Fang, Zhen;
Zhou, Qian;
Ren, Donglin;
Zou, Qi

Publication type:

Article

Multifaceted functions of tissue-resident memory T cells in tumorigenesis and cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04035-x

By:

Seo, Eun Sang;
Lee, Sung-Kyu;
Son, Young Min

Publication type:

Article

Blockade of TIGAR prevents CD8<sup>+</sup> T cell dysfunction and elicits anti-AML immunity.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04042-y

By:

Cui, Jialin;
Liu, Wenjie;
Zhong, Shiyang;
Fang, Yiran;
Xu, Pei;
Xu, Cheng;
Wang, Rong;
Hu, Xingfei;
Zhou, Wanting;
Li, Kening;
Hong, Ming;
Qian, Sixuan;
Sun, Qian

Publication type:

Article

Expression of the TIGIT axis and the CD39/CD73 purinergic pathway in bone metastasis-derived immune cells.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04030-2

By:

Brauneck, Elias;
Leonhardt, Leon-Gordian;
Assemissen, Anne Marie;
Wahid, Yagana;
Kruppa, Moritz;
Kruppa, Niklas;
Krüger, Julius;
Menzel, Stephan;
Koch-Nolte, Friedrich;
Kylies, Julian;
Weisel, Katja;
Bokemeyer, Carsten;
Wellbrock, Jasmin;
Fiedler, Walter;
Viezens, Lennart;
Brauneck, Franziska

Publication type:

Article

USP5 motivates immunosuppressive microenvironment in multiple myeloma by activating STAT2-PFKFB4-mediated glycolysis.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04031-1

By:

Long, Shifeng;
Ding, Ting;
Zheng, Yongliang;
Shao, Jinmei;
Liu, Yan;
Wang, Qinglan

Publication type:

Article

Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosis.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04046-8

By:

Villar, Sara;
Curis, Emmanuel;
Schlageter, Marie-Hélène;
Bosselut, Nelly;
Charbonnier, Amandine;
Rubio, Marie-Thérèse;
Turlure, Pascal;
Labussière, Hélène;
Bay, Jacques-Olivier;
Cornillon, Jérome;
Vincent, Laure;
Orvain, Corentin;
Kiladjian, Jean-Jacques;
Michonneau, David;
Socié, Gérard;
Robin, Marie

Publication type:

Article

Correction: Efficacy and safety of lenvatinib combined with anti-PD-1 antibodies plus GEMOX chemotherapy as non-first-line systemic therapy in advanced gallbladder cancer.

Published in:

2025

By:

Tan, Yang;
Liu, Kai;
Zhu, Chengpei;
Wang, Shanshan;
Wang, Yunchao;
Xue, Jingnan;
Ning, Cong;
Zhang, Nan;
Chao, Jiashuo;
Zhang, Longhao;
Long, Junyu;
Yang, Xiaobo;
Zeng, Daobing;
Zhao, Lijin;
Zhao, Haitao

Publication type:

Correction Notice

Combination of immune checkpoint inhibitors and anthracyclines as a potential first-line regimen for dedifferentiated liposarcoma: systematic review and meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04007-1

By:

Aobo, Zhuang;
Xiao, Zhou;
Chengfei, Xu;
Zhe, Xi;
Yingxue, Chen;
Chenhe, Zhang;
Fuan, Xie;
Fan, Yang;
Mengmeng, Xiao;
Feng, Ye;
Wengang, Li

Publication type:

Article

Identification and validation of poor prognosis immunoevasive subtype of esophageal cancer with tumor-infiltrating SAMD3 + NK cell abundance.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04028-w

By:

Huang, Xu;
You, Runze;
Liu, Fangyi;
Jian, Zitao;
Zhou, Guanyou;
Yin, Hao;
Wu, Mengyuan;
Sun, Tiantao;
Duan, Zhiyun;
Xu, Wenyi;
Zhang, Shaoyuan;
Yang, Xinyu;
Jiao, Heng;
Yang, Shuyi;
Wang, Qingle;
Yin, Jun;
Tang, Han;
Lin, Miao;
Tan, Lijie

Publication type:

Article

Identification and validation of poor prognosis immunoevasive subtype of esophageal cancer with tumor-infiltrating SAMD3 + NK cell abundance.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04028-w

By:

Huang, Xu;
You, Runze;
Liu, Fangyi;
Jian, Zitao;
Zhou, Guanyou;
Yin, Hao;
Wu, Mengyuan;
Sun, Tiantao;
Duan, Zhiyun;
Xu, Wenyi;
Zhang, Shaoyuan;
Yang, Xinyu;
Jiao, Heng;
Yang, Shuyi;
Wang, Qingle;
Yin, Jun;
Tang, Han;
Lin, Miao;
Tan, Lijie

Publication type:

Article

Identification of SURF4 and RALGAPA1 as promising therapeutic targets in glioblastoma and pan-cancer through integrative multi-omics, CRISPR-Cas9 screening and prognostic meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04034-y

By:

Wang, Fei;
Chen, Yuxuan;
Huang, Run;
Lu, Dengfeng;
Zhang, Juyi;
Yang, Yanbo;
Dang, Hanhan;
Liu, Meirong;
Chen, Zhouqing;
Sun, Xiaoou;
Wang, Zhong

Publication type:

Article

Prognostic nutrition index reveals LAG3 in cytotoxic CD8+ T cells and MHC class II in gastric cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04037-9

By:

Tsutsumi, Chikanori;
Ohuchida, Kenoki;
Imamura, Masaki;
Tan, Bryan;
Shimada, Yuki;
Son, Kiwa;
Kosai, Takaaki;
Katayama, Naoki;
Mochida, Yuki;
Hayashida, Sayuri;
Iwamoto, Chika;
Torata, Nobuhiro;
Horioka, Kohei;
Shindo, Koji;
Mizuuchi, Yusuke;
Ikenaga, Naoki;
Nakata, Kohei;
Oda, Yoshinao;
Nakamura, Masafumi

Publication type:

Article

Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04029-9

By:

Berclaz, Luc M.;
Burkhard-Meier, Anton;
Lechner, Axel;
Völkl, Michael;
Güler, Sinan E.;
Abdel-Rahman, Sultan;
Mansoorian, Sina;
Kunz, Wolfgang G.;
Knösel, Thomas;
Canis, Martin;
von Bergwelt-Baildon, Michael;
Issels, Rolf D.;
Di Gioia, Dorit;
Lindner, Lars H.

Publication type:

Article

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial).

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-04021-3

By:

D'Alterio, C.;
Rea, G.;
Napolitano, M.;
Coppola, E.;
Spina, A.;
Russo, D.;
Azzaro, R.;
Mignogna, C.;
Scognamiglio, G.;
Califano, D.;
Arenare, L.;
Schettino, C.;
Pisano, C.;
Cecere, S. C.;
Di Napoli, M.;
Passarelli, A.;
Perrone, F.;
Pignata, S.;
Scala, S.

Publication type:

Article

Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non–small cell lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2025, v. 74, n. 6, p. 1, doi. 10.1007/s00262-025-03984-7

By:

Deng, Jia-Yi;
Gao, Ming;
Fan, Xue;
Yan, Hong-Hong;
Luo, Wei-Chi;
Yang, Ming-Yi;
Yang, Xiao-Rong;
Chen, Zhi-Hong;
Xu, Chong-Rui;
Zhou, Qing

Publication type:

Article